The overall objective of the Neonatal Neuroprotection group is to identify and evaluate novel neuroprotective interventions to improve development and health in extremely vulnerable clinical populations.
From a clinical perspective, our research focus on three main groups of infants:
- Infants born extremely preterm,
- Infants who develop severe cerebral intraventricular hemorrhage, and
- Infants with severe congenital heart defects requiring surgery assisted by cardiopulmonary bypass
Through our research, we aim to:
- Build an increased understanding of the processes responsible for the development of brain damage and subsequent neurological and cognitive impairment
- Identify novel protective treatment strategies in order to improve neurodevelopment
Perioperative brain injury marker concentrations in neonatal open-heart surgery: a prospective observational study
Authors: Åsa Jungner, Finn Lennartsson, Isabella Björkman-Burtscher, Kaj Blennow, Henrik Zetterberg & David Ley. Front. Pediatr., 2023, Volume 11.
Full text: https://fluidsbarrierscns.biomedcentral.com/articles/10.1186/s12987-023-00460-1
NN-group will participate at the 8th World Congress of Pediatric Cardiology and Cardiac Surgery, August 27th – September 1st
Åsa Jungner will present data on the postoperative inflammatory response after neonatal open-heart surgery
NN-group will participate at jENS 2023: 5th Congress of joint European Neonatal Societies, September 19th – 23rd 2023
Amanda Kristiansson, David Ley and Claes Ekström will present at the meeting.